U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

FACTBOX: Making a flu vaccine can take months

Related Topics

Sun Apr 26, 2009 5:10pm EDT

(Reuters) - The U.N. World Health Organization and U.S. Centers for Disease Control and Prevention have been collecting samples of the new H1N1 swine flu virus to make a new vaccine in case it is needed.

Following are some facts about influenza vaccines.

* The WHO and CDC prepare samples of virus to give to industrial makers.

* These samples must be grown in specially produced chicken eggs. The virus is then purified and made into vaccines, a process that takes months.

* At least 20 companies make flu vaccines including Sanofi Pasteur, Australia's CSL Ltd, GlaxoSmithKline Plc, Novartis AG, Baxter and nasal spray maker MedImmune, acquired by AstraZeneca Plc.

* Experts agree the current process for making vaccines is clumsy and outdated, but new and more efficient technologies are still a few years away.

* WHO and CDC experts are trying to decide if a new vaccine for the H1N1 swine flu strain is needed, or perhaps if a fourth element could be added to the seasonal flu vaccine mix for next September.

* The health agencies also had been considering adding some vaccines against H5N1 avian influenza, which occasionally infects people and is also considered a major pandemic threat.

* Tests show the H1N1 component of the current seasonal flu vaccine does not protect against the new strain.

* Consulting firm Oliver Wyman found that drug companies would need four years to meet global demand for vaccines if a pandemic broke out today, but new technology could significantly boost production by 2014.

* Currently, drug makers could make up to 2.5 billion doses of pandemic vaccines in one year, meaning it would take four years to meet global demand, Oliver Wyman found. In a best-case scenario, they could make 7.7 billion doses in 1.5 years.

* Compounds called adjuvants can be used to boost a vaccine's effectiveness, so it could be diluted and used in more people.

* Current global demand for seasonal influenza vaccine is about 500 million doses a year.

* The CDC recommends that 261 million Americans -- 85 percent of the population -- should be vaccinated against flu. A RAND Corp. study in December showed that only about a third of those who should have did get the vaccine.

(Reporting by Maggie Fox; Editing by Will Dunham)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.